These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2252771)

  • 21. Pulmonary hypertension in hemodialysis patients without arteriovenous fistula: the effect of dialyzer composition.
    Kiykim AA; Horoz M; Ozcan T; Yildiz I; Sari S; Genctoy G
    Ren Fail; 2010; 32(10):1148-52. PubMed ID: 20954973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biocompatibility of dialysis membrane.
    Kes P
    Acta Med Croatica; 1999; 53(1):29-40. PubMed ID: 10437275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of two different high-flux dialysis membranes on insulin resistance in non-diabetic end-stage renal disease patients.
    Kara M; Gurluler E; Cakır U
    Ren Fail; 2015; 37(8):1293-6. PubMed ID: 26399977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hemodialysis membranes: a historical perspective, current state and future prospect.
    Cheung AK; Leypoldt JK
    Semin Nephrol; 1997 May; 17(3):196-213. PubMed ID: 9165649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients.
    Valeri A; Radhakrishnan J; Ryan R; Powell D
    Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-flux hemodialysis: overcoming the tyranny of time.
    Barth RH
    Contrib Nephrol; 1993; 102():73-97. PubMed ID: 8416190
    [No Abstract]   [Full Text] [Related]  

  • 31. Pressure effects on roller pump blood flow during hemodialysis.
    Depner TA; Rizwan S; Stasi TA
    ASAIO Trans; 1990; 36(3):M456-9. PubMed ID: 2252726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of increasing blood flow rate on dialysis adequacy in hemodialysis patients.
    Borzou SR; Gholyaf M; Zandiha M; Amini R; Goodarzi MT; Torkaman B
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):639-42. PubMed ID: 19587507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with urea reduction ratio in acute renal failure.
    Liangos O; Rao M; Ruthazer R; Balakrishnan VS; Modi G; Pereira BJ; Jaber BL
    Artif Organs; 2004 Dec; 28(12):1076-81. PubMed ID: 15554935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of hemodialysis (HD) membranes on interleukin 1-beta (IL-1 beta) production from peripheral blood mononuclear cells (PBMC).
    Momoi T; Ono M; Takagi T; Sugiura S; Ogawa H; Saito A
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S24-8. PubMed ID: 8608657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mathematical analysis of urea rebound in long-term hemodialysis patients.
    Ookawara S; Suzuki M; Saitou M; Tabei K
    Ther Apher Dial; 2005 Apr; 9(2):167-72. PubMed ID: 15828930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocompatibility and clinical performance of a new modified cellulose membrane.
    Bosch T; Schmidt B; Samtleben W; Gurland HJ
    Clin Nephrol; 1986; 26 Suppl 1():S22-9. PubMed ID: 3829464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biocompatibility study based on differential sequestration kinetics of CD14+CD16+ blood monocyte subsets with different dialyzers.
    Griveas I; Visvardis G; Sakellariou G; Passadakis P; Thodis I; Vargemezis V; Pavlitou A; Fleva A
    Ren Fail; 2006; 28(6):493-9. PubMed ID: 16928619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biocompatibility in long-term hemodialysis: facts--theories--clinical significance].
    Bosch TH; Blumenstein M; Gurland HJ
    Z Urol Nephrol; 1989 Feb; 82(2):69-76. PubMed ID: 2658418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Various methods for calculation of Kt/V: a clinical comparison.
    Ijelu G; Corona M; Raja RM
    ASAIO Trans; 1990; 36(3):M364-6. PubMed ID: 2252701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodialysis biocompatibility mathematical models to predict the inflammatory biomarkers released in dialysis patients based on hemodialysis membrane characteristics and clinical practices.
    Abdelrasoul A; Westphalen H; Saadati S; Shoker A
    Sci Rep; 2021 Nov; 11(1):23080. PubMed ID: 34845257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.